glp-1 receptor agonists for weight loss Agonists: A Comprehensive Overview GLP-1: Genetic Variants Related to

Chronic Weight Management in Obesity: Real-world evidence from a cohort of 175 adults with overweight or obesity shows semaglutide achieving mean weight reductions of 5.9 percent at 3 months and 10.9 percent at 6 months

What Are SGLT2 Inhibitors

Godfrey, H., Leibovit-Reiben, Z., et al

The debate over whether GLP-1 medications raise the risk of eye conditions that could lead to vision loss continues

Examples of other drugs that may be used for weight loss and weight management include: orlistat (Alli, Xenical) phentermine (Adipex-P, Lomaira) phentermine/topiramate (Qsymia) naltrexone/bupropion (Contrave) semaglutide (Wegovy) When you first start treatment with Saxenda, your doctor will gradually increase your dosage over a few weeks